JAK2 and acute lymphoblastic leukemia: Gain-of-function mutations in JAK2, frequently observed in ALL, are primarily located in exon 16, notably affecting arginine at position 683 (R683), which is most commonly substituted with glycine (R683G) or serine (R683S).